114 related articles for article (PubMed ID: 19592654)
21. Interleukin-22 deficiency accelerates the rejection of full major histocompatibility complex-disparate heart allografts.
Kapessidou P; Poulin L; Dumoutier L; Goldman M; Renauld JC; Braun MY
Transplant Proc; 2008 Jun; 40(5):1593-7. PubMed ID: 18589157
[TBL] [Abstract][Full Text] [Related]
22. An interaction between CD200 and monoclonal antibody agonists to CD200R2 in development of dendritic cells that preferentially induce populations of CD4+CD25+ T regulatory cells.
Gorczynski R; Khatri I; Lee L; Boudakov I
J Immunol; 2008 May; 180(9):5946-55. PubMed ID: 18424714
[TBL] [Abstract][Full Text] [Related]
23. CD200, a "no danger" signal for hair follicles.
Rosenblum MD; Yancey KB; Olasz EB; Truitt RL
J Dermatol Sci; 2006 Mar; 41(3):165-74. PubMed ID: 16386879
[TBL] [Abstract][Full Text] [Related]
24. Synthetic peptides from the N-terminal regions of CD200 and CD200R1 modulate immunosuppressive and anti-inflammatory effects of CD200-CD200R1 interaction.
Chen DX; He H; Gorczynski RM
Int Immunol; 2005 Mar; 17(3):289-96. PubMed ID: 15684038
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase suppression induced by clarithromycin in murine cardiac allografts.
Ogawa M; Suzuki J; Takayama K; Isobe M
Transplant Proc; 2009; 41(1):395-7. PubMed ID: 19249565
[TBL] [Abstract][Full Text] [Related]
26. Arsenic trioxide attenuated the rejection of major histocompatibility complex fully-mismatched cardiac allografts in mice.
Yan S; Zhang QY; Zhou B; Xue L; Chen H; Wang Y; Zheng SS
Transplant Proc; 2009 Jun; 41(5):1855-8. PubMed ID: 19545743
[TBL] [Abstract][Full Text] [Related]
27. Skin tolerance: in search of the Holy Grail.
Horner BM; Randolph MA; Huang CA; Butler PE
Transpl Int; 2008 Feb; 21(2):101-12. PubMed ID: 17903184
[TBL] [Abstract][Full Text] [Related]
28. The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts.
Noris M; Cassis P; Azzollini N; Cavinato R; Cugini D; Casiraghi F; Aiello S; Solini S; Cassis L; Mister M; Todeschini M; Abbate M; Benigni A; Trionfini P; Tomasoni S; Mele C; Garlanda C; Polentarutti N; Mantovani A; Remuzzi G
J Immunol; 2009 Oct; 183(7):4249-60. PubMed ID: 19734209
[TBL] [Abstract][Full Text] [Related]
29. Transgenic expression of cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin prolongs xenogeneic skin graft survival without extensive immunosuppression in rat burn wounds.
Wang Y; Wei H; Ni Y; Ge LP; Liu Q; Mao XL; Zhao YJ; Wu J
J Trauma; 2008 Jul; 65(1):154-62. PubMed ID: 18580521
[TBL] [Abstract][Full Text] [Related]
30. Lack of CD200 enhances pathological T cell responses during influenza infection.
Rygiel TP; Rijkers ES; de Ruiter T; Stolte EH; van der Valk M; Rimmelzwaan GF; Boon L; van Loon AM; Coenjaerts FE; Hoek RM; Tesselaar K; Meyaard L
J Immunol; 2009 Aug; 183(3):1990-6. PubMed ID: 19587022
[TBL] [Abstract][Full Text] [Related]
31. Systemic lipopolysaccharide (LPS)-induced microglial activation results in different temporal reduction of CD200 and CD200 receptor gene expression in the brain.
Masocha W
J Neuroimmunol; 2009 Sep; 214(1-2):78-82. PubMed ID: 19656578
[TBL] [Abstract][Full Text] [Related]
32. Generation of a tightly regulated doxycycline-inducible model for studying mouse intestinal biology.
Roth S; Franken P; van Veelen W; Blonden L; Raghoebir L; Beverloo B; van Drunen E; Kuipers EJ; Rottier R; Fodde R; Smits R
Genesis; 2009 Jan; 47(1):7-13. PubMed ID: 18942097
[TBL] [Abstract][Full Text] [Related]
33. Intestinal ischemia reperfusion and lipopolysaccharide transform a tolerogenic signal into a sensitizing signal and trigger rejection.
Kawai M; Kitade H; Koshiba T; Waer M; Pirenne J
Transplantation; 2009 May; 87(10):1464-7. PubMed ID: 19461482
[TBL] [Abstract][Full Text] [Related]
34. Cell-surface CD200 may predict efficacy of paternal mononuclear leukocyte immunotherapy in treatment of human recurrent pregnancy loss.
Clark DA
Am J Reprod Immunol; 2009 Jan; 61(1):75-84. PubMed ID: 19086995
[TBL] [Abstract][Full Text] [Related]
35. CD200: a putative therapeutic target in cancer.
Moreaux J; Veyrune JL; Reme T; De Vos J; Klein B
Biochem Biophys Res Commun; 2008 Feb; 366(1):117-22. PubMed ID: 18060862
[TBL] [Abstract][Full Text] [Related]
36. Control of viral immunoinflammatory lesions by manipulating CD200:CD200 receptor interaction.
Sarangi PP; Woo SR; Rouse BT
Clin Immunol; 2009 Apr; 131(1):31-40. PubMed ID: 19070547
[TBL] [Abstract][Full Text] [Related]
37. Effects of lipopolysaccharide on the induction of mixed chimerism in cyclophosphamide-induced tolerance.
Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R
Scand J Immunol; 2009 Nov; 70(5):423-30. PubMed ID: 19874546
[TBL] [Abstract][Full Text] [Related]
38. CD200R signaling in tumor tolerance and inflammation: A tricky balance.
Rygiel TP; Meyaard L
Curr Opin Immunol; 2012 Apr; 24(2):233-8. PubMed ID: 22264927
[TBL] [Abstract][Full Text] [Related]
39. Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production.
Win TS; Rehakova S; Negus MC; Saeb-Parsy K; Goddard M; Conlon TM; Bolton EM; Bradley JA; Pettigrew GJ
Circ Heart Fail; 2009 Jul; 2(4):361-9. PubMed ID: 19808360
[TBL] [Abstract][Full Text] [Related]
40. Proteomic profiling of acute cardiac allograft rejection.
Kienzl K; Sarg B; Golderer G; Obrist P; Werner ER; Werner-Felmayer G; Lindner H; Maglione M; Schneeberger S; Margreiter R; Brandacher G
Transplantation; 2009 Aug; 88(4):553-60. PubMed ID: 19696639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
